Skip to main content
SpringerLink
Log in

Cirrhose et transplantation: quand faut-il y penser?

  • Chapter
Post’U FMC-HGE

  • 368 Accesses

Résumé

La cirrhose est définie par une atteinte hépatique diffuse, caractérisée par une fibrose et la transformation de l’architecture normale du foie en nodules de régénération. Elle est le témoin d’un processus pathogène dont les causes établies sont nombreuses, alcool, virus B, C, maladies auto-immune ou métabolique au premier rang. La prévalence de la cirrhose n’est pas exactement connue. Sur certaines séries, une cirrhose peut être découverte dans 30 à 40% des cas lors de l’autopsie. On estime la prévalence de la cirrhose alcoolique en France d’environ 3 000 cas par million d’habitants.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. Oct 2010;53(4):762–768.

    Article  Google Scholar 

  2. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. Mar 25 2010;362(12):1071–1081.

    Article  PubMed  CAS  Google Scholar 

  3. Planas R, Montoliu S, Balleste B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. Nov 2006;4(11):1385–1394.

    Article  PubMed  Google Scholar 

  4. Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. Jul 1993;105(1):229–236.

    PubMed  CAS  Google Scholar 

  5. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. May 1 2004;363(9419):1461–1468.

    Article  PubMed  Google Scholar 

  6. Freeman RB, Jr. Transplantation for hepatocellular carcinoma: The Milan criteria and beyond. Liver Transpl. Nov 2006;12(11 Suppl 2):S8–13.

    Article  PubMed  Google Scholar 

  7. Mathurin P, Louvet A, Dharancy S. Treatment of severe forms of alcoholic hepatitis: where are we going? J Gastroenterol Hepatol. Mar 2008;23 Suppl 1: S60–62.

    Article  PubMed  CAS  Google Scholar 

  8. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. Amodel to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. Apr 2000;31(4):864–871.

    Article  PubMed  CAS  Google Scholar 

  9. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant. Feb 2005; 5(2):307–313.

    Article  PubMed  Google Scholar 

  10. Moller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol. Jul 2010; 53(1):179–190.

    Article  PubMed  Google Scholar 

  11. Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol. Apr 2010;52(4): 605–613.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, F-94800, France

    Audrey Coilly & Didier Samuel

  2. Univ. Paris-Sud, UMR-S785, Villejuif, F-94800, France

    Audrey Coilly & Didier Samuel

  3. Inserm, Unité 785, Villejuif, F-94800, France

    Didier Samuel

Authors
  1. Audrey Coilly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Didier Samuel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Audrey Coilly .

Editor information

Philippe Lévy

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Coilly, A., Samuel, D. (2011). Cirrhose et transplantation: quand faut-il y penser?. In: Lévy, P. (eds) Post’U FMC-HGE. Springer, Paris. https://doi.org/10.1007/978-2-8178-0237-4_34

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0237-4_34

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0236-7

  • Online ISBN: 978-2-8178-0237-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation